Leerink Maintains Outperform on BrightSpring Health Services (BTSG) March 2026
Leerink Partners has maintained an "Outperform" rating on BrightSpring Health Services (BTSG) following the company's Investor Day on March 18, 2026. This reaffirmation signals continued analyst confidence from the healthcare-focused firm, though no new public price target was issued. Despite the maintained positive rating, BTSG shares experienced a slight short-term decline.
Did BrightSpring’s Push into Acquisitions and High-Population CON States Just Shift Its (BTSG) Investment Narrative?
BrightSpring Health Services (BTSG) is actively pursuing acquisitions and expansions in high-population, certificate-of-need states, aiming for geographic density and capital-efficient growth. While this strategy could reshape its investment narrative, promising substantial revenue and earnings growth, it also introduces risks such as higher debt, integration challenges, and reimbursement dependence. Investors are urged to consider these factors alongside optimistic analyst forecasts suggesting a significant upside to its current price.
5 Relative Price Strength Picks for Choppy Market Phases
In a volatile market influenced by global events and mixed economic signals, identifying stocks with strong relative price strength is crucial. This article highlights five companies – The Allstate Corporation (ALL), Five Below (FIVE), Archrock (AROC), BrightSpring Health Services (BTSG), and The Beachbody Company (BODI) – that exhibit strong fundamentals and have outperformed the S&P 500, making them potentially lucrative investments during choppy market phases. The selection process involved specific screening parameters like Zacks Rank #1, positive estimate revisions, current price above $5, high trading volume, and favorable VGM scores.
A Look At BrightSpring Health Services (BTSG) Valuation After Analyst Upgrades And Specialty Pharmacy Growth Plans
BrightSpring Health Services (BTSG) has seen increased investor attention following its presentation at the Leerink Global Healthcare Conference, where it discussed efficiency efforts and specialty pharmacy growth. Analysts have upgraded the stock, which is currently trading at a 31% discount to their target despite a 124% increase over the past year. While one narrative suggests it is 23.4% undervalued with a fair value of $51.00, another view highlights its high P/E ratio of 74.9x, indicating potential overvaluation on current earnings.
Jon Rousseau Sells 220,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock
Jon Rousseau, an insider at BrightSpring Health Services (NASDAQ:BTSG), sold 220,000 shares of the company's stock for approximately $9.05 million. This transaction reduced his stake by 17.69%. Despite mixed Q4 fundamentals, with revenue up but EPS missing estimates and a high P/E ratio, the company has received "Buy" ratings from analysts and significant institutional investment, leading to a consensus target price of $44.08.
Lisa Nalley Sells 30,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock
Lisa Nalley, an insider at BrightSpring Health Services (NASDAQ:BTSG), recently sold 30,000 shares of the company's stock for $1,234,500, reducing her stake by over 21%. This sale comes amidst mixed fundamentals for the company, including strong revenue growth but an EPS miss, and the stock trading at a high P/E ratio near its 52-week high. Despite the insider sale, institutional investors have significantly increased their holdings, and analysts generally maintain a positive outlook with an average target price of $44.08.
Segall Bryant & Hamill LLC Acquires 42,840 Shares of BrightSpring Health Services, Inc. $BTSG
Segall Bryant & Hamill LLC recently increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 51.7%, purchasing an additional 42,840 shares to now own 125,768 shares valued at approximately $3.72 million. Despite a slight EPS miss last quarter, BrightSpring exceeded revenue expectations and analysts maintain a "Buy" rating with an average target price around $44.08, following several increased price targets from firms like Wells Fargo and Mizuho. The company's stock has seen positive sentiment from analysts and upward earnings estimate revisions.
Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase
Latham & Watkins LLP advised on BrightSpring Health Services, Inc.'s secondary offering of 20,000,000 shares of common stock at US$41.15 per share by certain selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. BrightSpring itself is not selling shares in this offering, and all proceeds will go to the selling stockholders. The offering is expected to close on March 4, 2026, with Latham's Capital Markets team, led by partners Marc Jaffe, Ian Schuman, and Kaj Nielsen, representing the underwriter.
Surging Earnings Estimates Signal Upside for BrightSpring Health Services, Inc. (BTSG) Stock
BrightSpring Health Services, Inc. (BTSG) is showing significant upside potential due to remarkably improving earnings outlooks and rising analyst optimism. The company has a Zacks Rank #1 (Strong Buy) indicating expected outperformance, with strong upward revisions in consensus estimates for both the upcoming quarter and the full year. This positive trend, correlated with near-term stock price movements, suggests further gains for investors.
BrightSpring Health Services (NASDAQ:BTSG) Upgraded by Zacks Research to "Strong-Buy" Rating
Zacks Research has upgraded BrightSpring Health Services (NASDAQ:BTSG) from a "hold" to a "strong-buy" rating, joining other analysts who have issued positive ratings and price target increases, leading to a consensus "Buy" rating and a target of $44.08. The company reported $3.55 billion in revenue (up 29.3% year-over-year) but narrowly missed EPS estimates at $0.33. Institutional investors are also showing increased interest in BTSG, with several firms raising or establishing new positions.
Royce & Associates LP Buys 44,505 Shares of BrightSpring Health Services, Inc. $BTSG
Royce & Associates LP significantly increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 32.2%, acquiring an additional 44,505 shares, bringing their total to 182,538 shares worth approximately $5.4 million. This move comes despite a recent large secondary offering by existing shareholders, which will increase the stock's float. The article also highlights strong bullish sentiment from Wall Street analysts, with several firms raising price targets and a consensus "Moderate Buy" rating, following BrightSpring's 29.3% year-over-year revenue growth.
Citigroup Inc. Buys 56,507 Shares of BrightSpring Health Services, Inc. $BTSG
Citigroup Inc. increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 42.2% in the third quarter, acquiring an additional 56,507 shares to own a total of 190,357 shares valued at approximately $5.63 million. This comes amidst a secondary offering of 20,000,000 shares by selling stockholders, which likely put downward pressure on the stock, despite concurrent share repurchase plans by management. Analysts largely maintain a "Moderate Buy" rating with an average price target of $42.85, as the stock trades around $40.65.
BrightSpring (NASDAQ: BTSG) resale: 20M shares, $822.7M public offering
BrightSpring Health Services (NASDAQ: BTSG) has filed a resale prospectus for 20 million shares of common stock by selling stockholders, with an offering price of $41.15 per share, totaling approximately $819.22 million in proceeds to the sellers. The company itself will not receive proceeds from this resale, except from cash exercises of management stock options. Concurrently, BrightSpring intends to repurchase and cancel 1,464,807 shares from the underwriter, contingent on the offering's closing, funding this buyback from cash on hand.
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
BrightSpring Health Services, Inc. announced the pricing of a secondary offering of 20,000,000 shares of common stock by certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P., at $41.15 per share. The company itself is not selling shares but will concurrently repurchase 1,464,807 shares from the underwriter. The offering is expected to close on March 4, 2026, with Goldman Sachs & Co. LLC acting as the sole book-running manager.
BrightSpring Health Services, Inc. $BTSG Shares Sold by Quantbot Technologies LP
Quantbot Technologies LP significantly reduced its stake in BrightSpring Health Services (NASDAQ:BTSG) by 53.8% in Q3, selling 114,883 shares and now holding 98,474 shares valued at $2.91 million. Despite this, BrightSpring reported strong revenue growth of 29.3% year-over-year, beating analyst estimates, although its EPS slightly missed projections. The company maintains a "Moderate Buy" consensus rating with an average analyst price target of $42.46, indicating a positive outlook despite its high P/E ratio.
TD Asset Management Inc Increases Holdings in BrightSpring Health Services, Inc. $BTSG
TD Asset Management Inc. significantly increased its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 18.3% during the third quarter, bringing its total ownership to 474,988 shares valued at approximately $14.04 million. This move follows BrightSpring's strong Q4 revenue beat, although EPS slightly missed expectations. The company currently holds a "Moderate Buy" consensus rating from analysts, with an average target price of $41.33.
Vanguard Group Inc. Acquires 576,906 Shares of BrightSpring Health Services, Inc. $BTSG
Vanguard Group Inc. increased its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 6.4% in the third quarter, acquiring an additional 576,906 shares to own a total of 9,604,703 shares. The article details other institutional investments in BrightSpring, highlights recent financial performance including Q4 revenue exceeding expectations, and provides analyst ratings. Despite a slight Q4 EPS miss, the company's revenue growth and 2026 guidance show positive sentiment.
BrightSpring Health Services (BTSG) EPS Jump In Q4 2025 Tests Bullish Profitability Narrative
BrightSpring Health Services (BTSG) reported a significant jump in Q4 2025 earnings per share (EPS) to US$0.24, with full-year net income of US$106.3 million on US$12.9 billion in revenue, marking a swing from a prior year loss. While this signals improving profitability, aligning with narratives of specialty pharmacy growth and efficiency, the company's high P/E ratio of 80.5x, compared to peers and the sector, and weak interest coverage, raise valuation and risk concerns for investors. The article highlights both bullish arguments for scaling profits and bearish concerns regarding current valuation and financial pressures.
BrightSpring Health Services Q4 FY25 earnings jump on strong revenue growth
BrightSpring Health Services (NASDAQ: BTSG) reported a significant increase in revenue and net income for Q4 FY25, with net revenue rising 29.3% to $3,551 million and net income climbing to $77.1 million. The company also saw adjusted EBITDA increase by 40.7% and acquired 107 home health and hospice branches. For fiscal 2026, management projects revenues between $14,450 million and $15,000 million.
BrightSpring Health Services Inc (BTSG) Shares Up 10.98% on Feb 27
BrightSpring Health Services Inc (BTSG) shares rose 10.98% on February 27, settling at $44.53. This places the stock near its 52-week high, with a trading volume of 961,805 shares. Wall Street analysts predict an average target price of $44.47, indicating an "Outperform" status from brokerage firms.
BrightSpring (NASDAQ: BTSG) swings to 2025 profit with growth
BrightSpring Health Services (NASDAQ: BTSG) reported a significant financial turnaround in 2025, swinging to a net profit of $189.1 million from a $20.5 million loss in 2024. The company's total revenues increased to $12.91 billion, and Adjusted EBITDA grew to $617.6 million. BrightSpring also provided optimistic 2026 guidance, expecting continued revenue and Adjusted EBITDA growth.
BrightSpring Health Services, Inc. SEC 10-K Report
BrightSpring Health Services, Inc. announced significant financial growth in its 2025 10-K report, with total revenues of $12.91 billion and a net income of $104.8 million, marking a strong turnaround in profitability. The company is strategically divesting its Community Living business for $835 million to focus on home-based healthcare services and expanding its presence through acquisitions and improved integrated care strategies. Despite challenges like intense competition and regulatory changes, BrightSpring aims for continued growth in value-based care and operational excellence.
UnitedHealth closes $239M sale of 107 home care locations
UnitedHealth has finalized the sale of 107 home care locations for $239 million, as reported by Diane Eastabrook on February 27, 2026. This divestiture is part of a larger transaction involving BrightSpring Health Services. The article, concise in nature, primarily announces the completion of this significant financial deal in the healthcare sector.
HighTower Advisors LLC Invests $3.63 Million in BrightSpring Health Services, Inc. $BTSG
HighTower Advisors LLC has initiated a new position in BrightSpring Health Services, Inc. (NASDAQ: BTSG), purchasing 122,625 shares valued at approximately $3.63 million. This investment highlights increasing institutional interest, with other major firms like Invesco and AllianceBernstein also significantly expanding their holdings. Analyst sentiment for BrightSpring Health Services is largely positive, with a "Moderate Buy" consensus rating and several recent price target increases.
TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)
TD Cowen has reiterated its bullish stance on BrightSpring Health Services, Inc. (BTSG), upgrading its price objective to $46 and maintaining a Buy rating, citing strong specialty generics trends. Other firms, including BMO Capital and BTIG, have also increased their price targets for BTSG, highlighting the company's competitive advantage, pharmaceutical ties, and consistent operational performance. The stock's recent performance is largely attributed to accelerated growth within its specialty division.
TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)
TD Cowen has upgraded its price objective for BrightSpring Health Services, Inc. (BTSG) to $46 from $42, maintaining a Buy rating due to strong specialty generics trends. BMO Capital and BTIG have also raised their price targets for BTSG, citing competitive positioning, solid pharmaceutical ties, and consistent performance. The company, which provides healthcare and pharmaceutical solutions, has shown impressive stock performance driven by growth in its specialty division.
Persistent Asset Partners Ltd Takes $2.25 Million Position in BrightSpring Health Services, Inc. $BTSG
Persistent Asset Partners Ltd has acquired a new position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) during the third quarter, purchasing 76,060 shares valued at approximately $2.25 million. This investment now represents 1.5% of Persistent Asset Partners Ltd's portfolio, making it their 15th largest holding. Several other institutional investors have also adjusted their stakes in BrightSpring Health Services, and Wall Street analysts currently rate the stock as a "Moderate Buy" with an average target price of $41.33.
Brightspring Health Services stock hits all-time high at 41.4 USD By Investing.com
Brightspring Health Services (BTSG) stock has reached an all-time high of $41.40, marking a significant 95.93% increase over the past year. This surge is attributed to strong market performance, strategic company initiatives, and positive analyst sentiment, with several firms raising price targets and maintaining "Buy" or "Overweight" ratings due to the company's robust growth in its specialty business and efficient operations.
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced it will host an Investor Day on Tuesday, March 17, 2026, starting at 8:30 a.m. ET. The event will feature presentations and Q&A sessions with the company's leadership team. BrightSpring provides home- and community-based health solutions, serving over 450,000 customers daily across all 50 states through pharmacy, home health, primary care, rehabilitation, and behavioral health services.
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
BrightSpring Health Services, Inc. (NASDAQ: BTSG) announced it will host an Investor Day on Tuesday, March 17, 2026, starting at 8:30 a.m. ET. The event will include presentations by the leadership team and Q&A sessions. A webcast will be available on the company's investor relations website, and in-person attendance is by invitation only for institutional investors and analysts.
BrightSpring plans March 17 Investor Day, most access via webcast
BrightSpring Health Services (NASDAQ: BTSG) announced it will host an Investor Day on March 17, 2026, featuring presentations from leadership and Q&A sessions. While in-person attendance is limited and by invitation, a live webcast and archived replay will be available on the company's investor relations website for broader access. Interested institutional investors and analysts can contact the company for invitation details.
A Look At BrightSpring Health Services (BTSG) Valuation After Bullish Analyst Actions And Strong Growth Signals
BrightSpring Health Services (BTSG) has garnered investor attention due to positive analyst sentiment, strong quarterly results, and consistent revenue and EPS growth. Although deemed modestly undervalued with a narrative fair value of $41.93, the company trades at a higher P/E ratio (74.3x) compared to industry averages, indicating potential valuation risk. Investors should consider future growth prospects and margin assumptions against the current premium valuation.
Lisanti Capital Growth LLC Makes New $1.96 Million Investment in BrightSpring Health Services, Inc. $BTSG
Lisanti Capital Growth LLC has made a new $1.96 million investment in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by acquiring 66,270 shares in the third quarter. This move aligns with a largely positive analyst sentiment, as the stock holds a "Moderate Buy" consensus rating and a target price of $40.92, with some analysts further raising their targets. BrightSpring Health Services, which specializes in home and community-based care, currently trades near its 52-week high and has a market capitalization of $7.08 billion.
Assessing BrightSpring Health Services (BTSG) Valuation After Fresh Bullish Analyst Interest
BrightSpring Health Services (BTSG) has garnered significant bullish analyst interest, with recent research pushing the stock onto investors' radars. Despite trading near $39.83, about 11% below the average analyst target and showing an intrinsic discount, its high P/E ratio of 74.6x raises questions about whether future growth is already priced in. Investors are advised to consider the company's ability to manage staffing costs and potential impacts from government reimbursement changes on its valuation.
BrightSpring Health Services (BTSG): Analyst Ratings Signal Strong Buy Amid 9.71% Potential Upside
BrightSpring Health Services (BTSG) is gaining investor attention due to its strong growth and favorable analyst ratings, with 16 buy ratings and a potential upside of 9.71%. The company, a leader in home and community-based healthcare services, shows robust revenue growth and solid EPS, but investors should monitor its negative free cash flow. Technical indicators suggest a positive trend, positioning BTSG as an intriguing prospect for growth-focused investors in the healthcare sector.
Brightspring Health Services stock hits all-time high at 123.4 USD
Brightspring Health Services Inc. (BTSGU) stock recently reached an all-time high of 123.4 USD, surpassing its previous 52-week high, driven by strong investor confidence and robust financial performance. The company has shown an impressive YTD return of 101.98% and a 1-year return of 92.78%, supported by 37.13% revenue growth and a "GREAT" financial health score. While trading slightly above its Fair Value with a P/E ratio of 63.45, this milestone highlights significant growth and a favorable position in the healthcare sector.
UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3
UBS has increased its price target for BrightSpring Health Services (NASDAQ:BTSG) to $42, reaffirming a Buy rating following the company's strong Q3 performance. BrightSpring reported significant revenue and adjusted EBITDA growth, driven by its Pharmacy Solutions segment, and raised its FY25 revenue guidance.
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
BrightSpring Health Services, Inc. announced a secondary offering of 15,000,000 shares of common stock by certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and management members. BrightSpring will not sell shares in this offering, and all proceeds will go to the selling stockholders. Concurrently, the company has authorized a repurchase of shares for up to $50.0 million from the underwriter.
Brightspring Health Services stock hits all-time high at 31.85 USD - Investing.com Nigeria
This article from Investing.com Nigeria indicates an application error preventing the display of content about Brightspring Health Services stock. The title suggests the stock reached an all-time high of $31.85 USD, but the detailed news is currently unavailable. The error message explicitly states a client-side exception occurred while loading the page.
Brightspring Health Services stock hits all-time high at 31.85 USD - Investing.com India
This article reports that Brightspring Health Services stock reached an all-time high of $31.85 USD. However, the content of the article is not fully available due to a client-side exception when loading the page. The headline provides the primary piece of information.
Earnings call transcript: Brightspring Health Q2 2025 shows 29% revenue growth - Investing.com Canada
The article indicates an earnings call transcript for Brightspring Health's Q2 2025, highlighting a 29% revenue growth. However, the content provided is an error message, suggesting that the full transcript is not available due to a client-side exception.
BrightSpring Health Services Set to Join S&P SmallCap 600 Index - MarketScreener
BrightSpring Health Services Inc. is set to replace Veritex Holdings Inc. in the S&P SmallCap 600 index on October 20. This move follows recent positive news for BrightSpring, including an increased price target from UBS and strong Q2 2025 earnings results. The company provides home and community-based healthcare services and pharmacy solutions across the US.
Why BrightSpring Health’s Stock is on a Rollercoaster - TipRanks
BrightSpring Health Services, Inc. (BTSG) is experiencing stock price volatility due to strong third-quarter results, particularly in its Pharmacy segment, and strategic growth initiatives. Analysts have raised price targets, suggesting further upside potential despite recent fluctuations. The article highlights BTSG's year-to-date price performance of 70.11% and a "Buy" technical sentiment signal.
Brightspring Health Services stock hits all-time high of 102.59 USD - Investing.com Canada
This article reports that Brightspring Health Services stock reached an all-time high of $102.59 USD. However, due to an application error, the full details of this report are unavailable. The content indicates a technical issue preventing the display of the complete news piece.
Brightspring Health Services stock hits all-time high of 102.59 USD - Investing.com Australia
This article reports a client-side application error when attempting to load content from Investing.com Australia. The intended article was about Brightspring Health Services stock hitting an all-time high of $102.59 USD. However, due to the error, the specific details of this event are unavailable.
UBS Adjusts BrightSpring Health Services Price Target to $35 From $31, Maintains Buy Rating - MarketScreener
UBS has increased its price target for BrightSpring Health Services (BTSG) to $35 from $31, while maintaining a Buy rating on the stock. This adjustment reflects an updated outlook on the healthcare services provider. The article itself is behind a paywall, preventing access to further details.
BrightSpring Health Services: Strong Buy Rating Backed by Robust Pharmacy Segment and Strategic Growth Initiatives - TipRanks
Analyst Charles Rhyee from TD Cowen maintained a Buy rating on BrightSpring Health Services, Inc. with a $41.00 price target, citing strong third-quarter results expectations driven by its Pharmacy segment and strategic growth initiatives. The company is expected to benefit from increased generic drug activity and new contracts for limited distribution drugs, aiming for specific leverage targets by late 2026. Wells Fargo also reiterated a Buy rating with a $33.00 price target.
BrightSpring Health Services Stock: What’s Driving the Buzz? - TipRanks
BrightSpring Health Services (BTSG) is experiencing stock price volatility as multiple analysts, including UBS and Wells Fargo, have raised their price targets due to the company's strong performance and favorable market conditions. Despite its closing price, the consensus price target suggests potential for further upside, driven by the company's growth potential and strategic initiatives. The article provides key financial metrics for BTSG, including YTD price performance, average trading volume, and current market capitalization.
|BrightSpring Health Services (BTSG) Stock Analysis: A 5.54% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
|BrightSpring Health Services (NASDAQ: BTSG) is attracting investor attention due to its substantial revenue growth of 29.10% and a potential 5.54% upside based on analyst price targets. The healthcare company, operating through Pharmacy Solutions and Provider Services segments, currently has a market capitalization of $5.02 billion and strong bullish sentiment from analysts. Despite negative free cash flow, reinvestment into the business and technical indicators suggest a solid, albeit potentially overbought, growth trajectory.
BrightSpring Health Services to Announce Q3 2025 Financial Results on October 31, 2025 | BTSG Stock News
BrightSpring Health Services (NASDAQ: BTSG) announced it will release its Q3 2025 financial results on October 31, 2025, followed by a conference call at 8:30 a.m. ET. The company, which provides home- and community-based health solutions to over 460,000 customers daily, will make the webcast available on its investor relations website. The announcement includes detailed insider trading activity, hedge fund movements, and recent analyst ratings and price targets for BTSG stock.
